Skip to content
Screener

Zimmer Biomet Holdings ZBH Additions To Instruments

Additions To Instruments at other companies

DHI Group logo
DHI GroupDHX
$00.0%
DHI Group logo
DHI GroupDHX
0.1%0.0pp
PROG Holdings logo
PROG HoldingsPRG
$389.98M+1.2%
CuriosityStream logo
CuriosityStreamCURI
-$4.03M-120%
Teradata logo
TeradataTDC
$1M
Teradata logo
TeradataTDC
$1M

Other financials

Income statement

See full
Revenue$2.2B+4.8%
Gross profit$1.5B+3.8%
Operating income$326.1M+8.7%
Net income$198.3M+29.8%
EPS (diluted)$1.03+33.8%

Balance sheet

See full
Cash & equivalents$410.0M-26.4%
Total debt$7.5B-1.2%
Total equity$12.6B+0.8%
Total assets$22.8B-0.3%

Cash flow

See full
Operating cash flow$447.8M+18.4%
CapEx$54.2M+8.2%
Free cash flow$393.6M+20.0%

Valuation

See full
Market cap$18.42B-7.1%
Enterprise value$25.48B-5.0%
P/E22.8×-1.2×
P/S2.2×-0.4×

Profitability

See full
Gross margin69.9%-1.2pp
Operating margin14.2%-1.9pp
Net margin9.5%-1.0pp
FCF margin17.9%-0.9pp

Returns & leverage

See full
Return on equity6.4%-0.1pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.2×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept zbh:AdditionsToInstruments.

The source filing: Zimmer Biomet Holdings’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335044
Line itemFor the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Other assets and liabilities26.18.3
Net cash provided by operating activities807.2761.0
Cash flows provided by (used in) investing activities:
Additions to instruments(162.6)(140.2)
Additions to other property, plant and equipment(90.5)(94.7)
Net investment hedge settlements10.83.5
Business combination investments, net of acquired cash-(1,226.3)
Acquisition of intangible assets(101.2)(32.4)

Item 1. Financial Statements

FAQ

What is Zimmer Biomet Holdings's additions to instruments?
Zimmer Biomet Holdings (ZBH) reported additions to instruments of $85.4M in Q2 2026.
How has Zimmer Biomet Holdings's additions to instruments changed year-over-year?
Zimmer Biomet Holdings's additions to instruments increased by 6.1% year-over-year, from $80.5M to $85.4M.
What is the long-term trend for Zimmer Biomet Holdings's additions to instruments?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's additions to instruments has grown at a 2.4% compound annual growth rate (CAGR), from $273.6M to $300.5M.
What does additions to instruments mean?
This represents capital expenditures specifically related to surgical instruments and loaner sets used by surgeons. These are essential assets for medical device companies to facilitate the use of their implants.

Ask your AI about Zimmer Biomet Holdings's additions to instruments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude